Institutional investors hold a majority ownership of BCR through the 81.64% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended June 2017, these large investors purchased a net $5.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FARALLON CAPITAL MANAGEMENT LLC Bought 1.5 Million shares of C R Bard Inc
ARROWGRASS CAPITAL PARTNERS (US)... Bought 1.0 Million shares of C R Bard Inc
ALPINE ASSOCIATES MANAGEMENT, IN... Bought 840.4 Thousand shares of C R Bard Inc